Basics Annexon, Inc. Common Stock IPO Date: August 1, 2020 Sector: Healthcare Industry: Biotech Market Cap: $274.29M Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 3.70% Avg Daily Range (30 D): $0.08 | 3.20% Avg Daily Range (90 D): $0.09 | 4.21% Institutional Daily Volume Avg Daily Volume: .67M Avg Daily Volume (30 D): 1.5M Avg Daily Volume (90 D): 1.58M Trade Size Avg Trade Size (Sh.): 126 Avg Trade Size (Sh.) (30 D): 168 Avg Trade Size (Sh.) (90 D): 184 Institutional Trades Total Inst.Trades: 636 Avg Inst. Trade: $1.6M Avg Inst. Trade (30 D): $.75M Avg Inst. Trade (90 D): $1.18M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.01M Avg Closing Trade (30 D): $.64M Avg Closing Trade (90 D): $1.67M Avg Closing Volume: 282.84K     News Jul 24, 2025 @ 11:00 AM Annexon Announces Completion of Enrollment in Pivo... Source: Annexon, Inc. Jun 3, 2025 @ 5:00 PM Huntington’s Disease Clinical Trial Pipelin... Source: Delveinsight May 9, 2025 @ 9:00 PM Annexon Announces Presentations on the Clinical Ad... Source: N/A Apr 3, 2025 @ 10:18 PM Annexon Highlights Leadership in Advancing Clinica... Source: N/A Jan 7, 2025 @ 1:00 PM Annexon Biosciences to Present at the 43rd Annual ... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.37 $-.25 $-.23 Diluted EPS $-.37 $-.25 $-.23 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -54.36M $ -34.82M $ -29.61M Operating Income / Loss $ -57.41M $ -39.44M $ -33.58M Cost of Revenue $ $ $ Net Cash Flow $ 47.62M $ -77.76M $ 5.36M PE Ratio